543 related articles for article (PubMed ID: 25453052)
21. Dual receptor-targeting ⁹⁹mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Xu J; Yang J; Miao Y
Nucl Med Biol; 2015 Apr; 42(4):369-74. PubMed ID: 25577037
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of new Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides for melanoma imaging.
Flook AM; Yang J; Miao Y
Mol Pharm; 2013 Sep; 10(9):3417-24. PubMed ID: 23885640
[TBL] [Abstract][Full Text] [Related]
23. Melanoma targeting with [
Carta D; Salvarese N; Morellato N; Gao F; Sihver W; Pietzsch HJ; Biondi B; Ruzza P; Refosco F; Carpanese D; Rosato A; Bolzati C
Nucl Med Biol; 2016 Dec; 43(12):788-801. PubMed ID: 27694057
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
25. Melanoma targeting property of a Lu-177-labeled lactam bridge-cyclized alpha-MSH peptide.
Guo H; Miao Y
Bioorg Med Chem Lett; 2013 Apr; 23(8):2319-23. PubMed ID: 23473679
[TBL] [Abstract][Full Text] [Related]
26. Facile preparation of a novel Ga-67-labeled NODAGA-conjugated lactam-cyclized alpha-MSH peptide at room temperature for melanoma targeting.
Xu J; Qiao Z; Gonzalez R; Miao Y
Bioorg Med Chem Lett; 2020 Dec; 30(24):127627. PubMed ID: 33141072
[TBL] [Abstract][Full Text] [Related]
27. Melanoma-Targeting Property of Y-90-Labeled Lactam-Cyclized α-Melanocyte-Stimulating Hormone Peptide.
Xu J; Yang J; Gonzalez R; Fisher DR; Miao Y
Cancer Biother Radiopharm; 2019 Nov; 34(9):597-603. PubMed ID: 31644317
[No Abstract] [Full Text] [Related]
28. Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting.
Yang J; Xu J; Cheuy L; Gonzalez R; Fisher DR; Miao Y
Mol Pharm; 2019 Apr; 16(4):1694-1702. PubMed ID: 30763112
[TBL] [Abstract][Full Text] [Related]
29. Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.
Guo H; Yang J; Gallazzi F; Prossnitz ER; Sklar LA; Miao Y
Bioconjug Chem; 2009 Nov; 20(11):2162-8. PubMed ID: 19817405
[TBL] [Abstract][Full Text] [Related]
30. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
31. Cu-64-labeled lactam bridge-cyclized α-MSH peptides for PET imaging of melanoma.
Guo H; Miao Y
Mol Pharm; 2012 Aug; 9(8):2322-30. PubMed ID: 22780870
[TBL] [Abstract][Full Text] [Related]
32. Substitution of Gly with Ala enhanced the melanoma uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.
Yang J; Miao Y
Bioorg Med Chem Lett; 2012 Feb; 22(4):1541-5. PubMed ID: 22297112
[TBL] [Abstract][Full Text] [Related]
33. Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide.
Yang J; Flook AM; Feng C; Miao Y
Bioorg Med Chem Lett; 2014 Jan; 24(1):195-8. PubMed ID: 24316121
[TBL] [Abstract][Full Text] [Related]
34. Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides.
Flook AM; Yang J; Miao Y
J Med Chem; 2014 Nov; 57(21):9010-8. PubMed ID: 25290883
[TBL] [Abstract][Full Text] [Related]
35. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Yang J; Guo H; Miao Y
Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
[TBL] [Abstract][Full Text] [Related]
37. The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH.
Teixeira V; Fernández M; Oddone N; Zhang X; Gallazzi F; Cerecetto H; Gambini JP; Porcal W; Cabral P; Quinn TP
Anticancer Agents Med Chem; 2017; 17(8):1144-1152. PubMed ID: 27924732
[TBL] [Abstract][Full Text] [Related]
38. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
39. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
40. Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide.
Yang J; Guo H; Padilla RS; Berwick M; Miao Y
Bioorg Med Chem; 2010 Sep; 18(18):6695-700. PubMed ID: 20728365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
